首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1782076

組織工程與再生醫學：技術與全球市場

Tissue Engineering and Regeneration: Technologies and Global Markets

出版日期: 2025年07月25日 | 出版商:

BCC Research | 英文 131 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球組織工程和再生醫學市場預計將從2024年的48億美元和2025年的54億美元成長到2030年的98億美元，2025年至2030年的年複合成長率為 12.8%。

預計北美市場規模將從2024年的21億美元和2025年的24億美元成長到2030年的45億美元，預測期內年複合成長率為13.3%。預計亞太市場規模將從2024年的8.884億美元成長到2025年的10億美元，年複合成長率為15.5%，到2030年將達到21億美元。

本報告研究了全球組織工程和再生醫學市場，並提供了市場概況、市場影響因素和市場機會分析、市場規模趨勢和預測以及各個細分市場和地區的詳細分析。

新興技術
3D生物列印
器官晶片
智慧生醫材料
AI
臨床試驗分析
關鍵要點
臨床試驗分析：依研究類型
臨床試驗分析：依狀態
臨床試驗分析：依階段
專利分析
關鍵要點
專利：依年份
專利：依主要申請人
專利：依最高所有者
專利：依管轄範圍

第7章市場區隔分析

細分市場
市場分析：依產品類型
關鍵要點
鷹架
生物來源支架
合成支架
接枝
同種異體移植
自體移植
合成移植物
異質骨移植
市場分析：依材料
關鍵要點
生物來源材料
合成材料
市場分析：依應用
關鍵要點
整形外科和肌肉骨骼疾病
皮膚病學和創傷護理
牙科疾病
心血管疾病
其他
地理分佈
各地區市場分析
關鍵要點
北美洲
歐洲
亞太地區
中東和非洲
南美洲

第8章競爭訊息

關鍵要點
競爭格局
主要企業全球市場佔有率
關鍵發展和策略

第9章組織工程與再生醫學的永續性：ESG 視角

ESG：簡介
組織工程與再生醫學的永續性：ESG視角
關鍵 ESG 議題
組織工程與再生醫學：ESG績效分析
BCC的結論

第10章附錄

調查方法
來源
簡稱
公司簡介
ABBVIE INC.
ALICORN MEDICAL PVT. LTD.
BAXTER
B. BRAUN SE
BD
BIOTISSUE
INTEGRA LIFESCIENCES
JOHNSON & JOHNSON SERVICES INC.
MEDTRONIC
MIMEDX GROUP INC.
ORGANOGENESIS INC.
SMITH+NEPHEW
STRYKER
TECNOSS
ZIMMER BIOMET
新興Start-Ups/市場顛覆者

簡介目錄圖表

Product Code: HLC101E

The global market for tissue engineering and regeneration was valued at $4.8 billion in 2024 and is estimated to increase from $5.4 billion in 2025 to reach $9.8 billion by 2030, at a compound annual growth rate (CAGR) of 12.8% from 2025 through 2030.

The North American market for tissue engineering and regeneration was valued at $2.1 billion in 2024 and is estimated to increase from $2.4 billion in 2025 to reach $4.5 billion by 2030, at a CAGR of 13.3% from 2025 through 2030.

The Asia-Pacific market for tissue engineering and regeneration was valued at $888.4 million in 2024 and is estimated to increase from $1 billion in 2025 to reach $2.1 billion by 2030, at a CAGR of 15.5% from 2025 through 2030.

Report Scope

The report provides an overview of the global tissue engineering and regeneration market and analyzes market trends. It includes global revenue ($ million) using 2024 as the base year, estimated data for 2025, and projected data for 2026 through 2030.

The market is segmented into product type, material, and application. By product, the market is categorized into scaffolds and tissue grafts. By material, the market is segmented into biologically derived materials and synthetic materials. Based on application, the market is segmented into orthopedic and musculoskeletal disorders, dermatology and wound care, dental disorders, cardiovascular diseases, and others. Geographical regions covered in this study are North America (the U.S., Canada, and Mexico), Europe (Germany, the U.K., Italy, France, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), the Middle East and Africa (MEA), and South America, focusing on all the major countries in these regions.

The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses emerging technologies related to the market.

The report concludes by analyzing the competitive landscape and providing the ranking/share of key global tissue engineering and regeneration companies. It also contains a dedicated section of company profiles that covers details such as overview, key financials, product portfolio and recent developments in major companies.

Report Includes

47 data tables and 64 additional tables
Analyses of the trends in global markets for tissue engineering and regeneration technologies, with historic revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
Estimates of the market's size and revenue prospects, accompanied by a market share analysis by product type, material, application and region
Facts and figures pertaining to market dynamics, technological advances, regulations and the impact of macroeconomic factors
Insights derived from Porter's Five Forces model, as well as global supply chain analysis
Patent analysis, featuring key granted and published patents
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Company profiles of major players within the industry, including Organogenesis Inc., Integra LifeSciences, Smith+Nephew, MiMedx Group Inc., and Johnson & Johnson Services Inc.

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Overview
Porter's Five Forces Analysis in the Tissue Engineering and Regeneration Market
Potential for New Entrants (Moderate to High)
Bargaining Power of Suppliers (Moderate to High)
Bargaining Power of Buyers (High)
Threat of Substitutes (Low to Moderate)
Competition in the Industry (High)
Macroeconomic Factor Analysis
Aging Population
Regulatory Environment
Government Policy and Collaboration
The U.S. Tariff Scenario

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Rising Demand for Regenerative Medicine
Growing Research and Approvals in Tissue Engineering
Increasing Venture Capital Funding
Market Restraints
High Cost Associated with Treatment
Complex Regulatory Pathway
Market Opportunities
Technological Advances
Emerging Economies

Chapter 4 Regulatory Landscape

The U.S.
Europe
Asia-Pacific

Chapter 5 Impact of AI Adoption on the Tissue Engineering and Regeneration Market

Overview
Case Studies
Problem
Solution
Outcome
AI Adoption: Trends
Adoption Trends in North America
Adoption Trends in Europe
Adoption Trends in the Rest of the World
AI Disruption Trends
Impact of AI on Various Stages of the Value Chain
Market Spending and Investment Scenario
VC Investment in AI

Chapter 6 Emerging Technologies and Developments

Emerging Technologies
3D Bioprinting
Organ-on-a-Chip
Smart Biomaterial
Artificial Intelligence
Clinical Trials Analysis
Key Takeaways
Clinical Trials Analysis, by Type of Study
Clinical Trials Analysis, by Status
Clinical Trials Analysis, by Phase
Patent Analysis
Key Takeaways
Patents, by Year
Patents by Top Applicant
Patents by Top Owner
Patents by Jurisdiction

Chapter 7 Market Segmentation Analysis

Segmentation Breakdown
Market Analysis by Product Type
Key Takeaways
Scaffolds
Biological Scaffolds
Synthetic Scaffolds
Grafts
Allogenic
Autogenic
Synthetic
Xenogeneic
Market Analysis by Material
Key Takeaways
Biologically Derived Material
Synthetic Material
Market Analysis by Application
Key Takeaways
Orthopedics and Musculoskeletal Disorders
Dermatology and Wound Care
Dental Disorders
Cardiovascular Diseases
Others
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa (MEA)
South America

Chapter 8 Competitive Intelligence

Key Takeaways
Competitive Landscape
Global Market Shares of Leading Companies
Key Developments and Strategies

Chapter 9 Sustainability in Tissue Engineering and Regeneration: An ESG Perspective

Introduction to ESG
Sustainability in Tissue Engineering and Regeneration: An ESG Perspective
Key ESG Issues
Tissue Engineering and Regeneration ESG Performance Analysis
Concluding Remarks from BCC

Chapter 10 Appendix

Methodology
Sources
Abbreviations
Company Profiles
ABBVIE INC.
ALICORN MEDICAL PVT. LTD.
BAXTER
B. BRAUN SE
BD
BIOTISSUE
INTEGRA LIFESCIENCES
JOHNSON & JOHNSON SERVICES INC.
MEDTRONIC
MIMEDX GROUP INC.
ORGANOGENESIS INC.
SMITH+NEPHEW
STRYKER
TECNOSS
ZIMMER BIOMET
A Few Emerging Start-ups/Market Disruptors

簡介目錄圖表

List of Tables

Summary Table : Global Market for Tissue Engineering and Regeneration, by Region, Through 2030
Table 1 : Porter's Five Forces Analysis: Overview
Table 2 : Tissue Engineering and Regeneration: Venture Capital Funding, 2024
Table 3 : Tissue Engineering & Regeneration: Pricing
Table 4 : Tissue Engineering and Regeneration: Regulatory Overview, 2025
Table 5 : Asia-Pacific: Regulatory Landscape, 2024
Table 6 : Clinical Trials in Tissue Engineering, by Type of Study, June 2025
Table 7 : Clinical Trials in Tissue Engineering, by Status, June 2025
Table 8 : Clinical Trials in Tissue Engineering, by Phase, June 2025
Table 9 : Patents, by Top Applicant, 2021-2024
Table 10 : Patents, by Top Owner, 2021-2024
Table 11 : Patents, by Jurisdiction, 2021-2024
Table 12 : Global Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
Table 13 : Comparison of Extracellular Matrix Functions and Scaffold Analogs in Tissue Engineering
Table 14 : Global Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
Table 15 : Biological Scaffold Materials: Advantages and Disadvantages
Table 16 : Synthetic Scaffold Materials: Advantages and Disadvantages
Table 17 : Global Market for Grafts in Tissue Engineering and Regeneration, by Source, Through 2030
Table 18 : List of Bioengineered Autogenic Grafts
Table 19 : Global Market for Tissue Engineering and Regeneration, by Material, Through 2030
Table 20 : Tissue Engineering and Regeneration: Biomaterial
Table 21 : Global Market for Tissue Engineering and Regeneration, by Application, Through 2030
Table 22 : Orthopedics and Musculoskeletal Disorders: Tissue Engineering and Regeneration Product
Table 23 : Dermatology and Wound Care: Tissue Engineering and Regeneration Products
Table 24 : Global Market for Tissue Engineering and Regeneration, by Region, Through 2030
Table 25 : North American Market for Tissue Engineering and Regeneration, by Country, Through 2030
Table 26 : North American Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
Table 27 : North American Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
Table 28 : North American Market for Grafts in Tissue Engineering and Regeneration, by Source, Through 2030
Table 29 : North American Market for Tissue Engineering and Regeneration, by Material, Through 2030
Table 30 : North American Market for Tissue Engineering and Regeneration, by Application, Through 2030
Table 31 : European Market for Tissue Engineering and Regeneration, by Country, Through 2030
Table 32 : European Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
Table 33 : European Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
Table 34 : European Market for Grafts in Tissue Engineering and Regeneration, by Source, Through 2030
Table 35 : European Market for Tissue Engineering and Regeneration, by Material, Through 2030
Table 36 : European Market for Tissue Engineering and Regeneration, by Application, Through 2030
Table 37 : Asia-Pacific Market for Tissue Engineering and Regeneration, by Country, Through 2030
Table 38 : Asia-Pacific Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
Table 39 : Asia-Pacific Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
Table 40 : Asia-Pacific Market for Graft in Tissue Engineering and Regeneration, by Source, Through 2030
Table 41 : Asia-Pacific Market for Tissue Engineering and Regeneration, by Material, Through 2030
Table 42 : Asia-Pacific Market for Tissue Engineering and Regeneration, by Application, Through 2030
Table 43 : MEA Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
Table 44 : MEA Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
Table 45 : MEA Market for Graft in Tissue Engineering and Regeneration, by Source, Through 2030
Table 46 : MEA Market for Tissue Engineering and Regeneration, by Material, Through 2030
Table 47 : MEA Market for Tissue Engineering and Regeneration, by Application, Through 2030
Table 48 : South American Market for Tissue Engineering and Regeneration, by Product Type, Through 2030
Table 49 : South American Market for Scaffolds in Tissue Engineering and Regeneration, by Type, Through 2030
Table 50 : South American Market for Graft in Tissue Engineering and Regeneration, by Source, Through 2030
Table 51 : South American Market for Tissue Engineering and Regeneration, by Material, Through 2030
Table 52 : South American Market for Tissue Engineering and Regeneration, by Application, Through 2030
Table 53 : Top 5 Leading Manufacturers of Tissue Engineering and Regeneration Market, 2024
Table 54 : Tissue Engineering and Regeneration: Recent Strategic Developments, 2022-2025
Table 55 : ESG Rankings in Tissue Engineering and Regeneration Companies, 2025*
Table 56 : ESG: Environmental Overview
Table 57 : ESG: Social Overview
Table 58 : ESG: Governance Overview
Table 59 : Report Information Sources
Table 60 : Abbreviations Used in the Global Tissue Engineering and Regeneration Market Report
Table 61 : AbbVie Inc.: Company Snapshot
Table 62 : AbbVie Inc.: Financial Performance, FY 2023 and 2024
Table 63 : AbbVie Inc.: Product Portfolio
Table 64 : AbbVie Inc.: News/Key Developments, 2023
Table 65 : Alicorn Medical Pvt. Ltd.: Company Snapshot
Table 66 : Alicorn Medical Pvt. Ltd.: Product Portfolio
Table 67 : Alicorn Medical Pvt. Ltd.: News/Key Developments, 2025
Table 68 : Baxter: Company Snapshot
Table 69 : Baxter: Financial Performance, FY 2023 and 2024
Table 70 : Baxter: Product Portfolio
Table 71 : B. Braun SE: Company Snapshot
Table 72 : B. Braun SE: Financial Performance, FY 2023 and 2024
Table 73 : B. Braun SE: Product Portfolio
Table 74 : BD: Company Snapshot
Table 75 : BD: Financial Performance, FY 2023 and 2024
Table 76 : BD: Product Portfolio
Table 77 : BD: News/Key Developments, 2025
Table 78 : BioTissue: Company Snapshot
Table 79 : BioTissue: Product Portfolio
Table 80 : BioTissue: News/Key Developments, 2022 and 2024
Table 81 : Integra LifeSciences: Company Snapshot
Table 82 : Integra LifeSciences: Financial Performance, FY 2023 and 2024
Table 83 : Integra LifeSciences: Product Portfolio
Table 84 : Integra LifeSciences: News/Key Developments, 2022
Table 85 : Johnson & Johnson Services Inc.: Company Snapshot
Table 86 : Johnson & Johnson Services Inc.: Financial Performance, FY 2023 and 2024
Table 87 : Johnson & Johnson Services Inc.: Product Portfolio
Table 88 : Medtronic: Company Snapshot
Table 89 : Medtronic: Financial Performance, FY 2023 and 2024
Table 90 : Medtronic: Product Portfolio
Table 91 : MIMEDX Group Inc.: Company Snapshot
Table 92 : MIMEDX Group Inc.: Financial Performance, FY 2023 and 2024
Table 93 : MIMEDX Group Inc.: Product Portfolio
Table 94 : MIMEDX Group Inc.: News/Key Developments, 2022-2024
Table 95 : Organogenesis Inc.: Company Snapshot
Table 96 : Organogenesis Inc.: Financial Performance, FY 2023 and 2024
Table 97 : Organogenesis Inc.: Product Portfolio
Table 98 : Smith+Nephew: Company Snapshot
Table 99 : Smith+Nephew: Financial Performance, FY 2023 and 2024
Table 100 : Smith+Nephew: Product Portfolio
Table 101 : Smith+Nephew: News/Key Developments, 2023 and 2024
Table 102 : Stryker: Company Snapshot
Table 103 : Stryker: Financial Performance, FY 2023 and 2024
Table 104 : Stryker: Product Portfolio
Table 105 : Tecnoss: Company Snapshot
Table 106 : Tecnoss: Product Portfolio
Table 107 : Zimmer Biomet: Company Snapshot
Table 108 : Zimmer Biomet: Financial Performance, FY 2023 and 2024
Table 109 : Zimmer Biomet: Product Portfolio
Table 110 : List of a Few Emerging Start-ups/ Market Disruptors

List of Figures

Summary Figure : Global Market Shares of Tissue Engineering and Regeneration, by Region, 2024
Figure 1 : Tissue Engineering: Triad
Figure 2 : Porter's Five Forces Analysis of the Tissue Engineering and Regeneration Market
Figure 3 : Market Dynamics of Tissue Engineering and Regeneration
Figure 4 : Number of Publications, by Year, 2021-2024
Figure 5 : AI in Tissue Engineering
Figure 6 : AI: Global Leaders, Ranking, 2025
Figure 7 : Impact of AI on Key Industry Verticals
Figure 8 : Impact of AI on Value Chain
Figure 9 : Emerging Trends/Technologies in the Tissue Engineering and Regeneration Market
Figure 10 : Patents Granted, by Year, 2021-2024
Figure 11 : Global Market Shares of Tissue Engineering and Regeneration, by Product Type, 2024
Figure 12 : Global Market Shares of Scaffolds in Tissue Engineering and Regeneration, by Type, 2024
Figure 13 : Global Market Shares of Grafts in Tissue Engineering and Regeneration, by Source, 2024
Figure 14 : Global Market Shares of Tissue Engineering and Regeneration, by Material, 2024
Figure 15 : Global Market Shares of Tissue Engineering and Regeneration, by Application, 2024
Figure 16 : Global Market Shares of Tissue Engineering and Regeneration, by Region, 2024
Figure 17 : North American Market Shares of Tissue Engineering and Regeneration, by Country, 2024
Figure 18 : European Market Shares of Tissue Engineering and Regeneration, by Country, 2024
Figure 19 : Asia-Pacific Market Shares of Tissue Engineering and Regeneration, by Country, 2024
Figure 20 : Company Share Analysis of Tissue Engineering and Regeneration Market, 2024
Figure 21 : ESG Pillars
Figure 22 : Advantages of ESG for Companies
Figure 23 : AbbVie Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 24 : AbbVie Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 25 : Baxter: Revenue Shares, by Business Unit, FY 2024
Figure 26 : Baxter: Revenue Shares, by Country/Region, FY 2024
Figure 27 : B. Braun SE: Revenue Shares, by Business Unit, FY 2024
Figure 28 : B. Braun SE: Revenue Shares, by Country/Region, FY 2024
Figure 29 : BD: Revenue Shares, by Business Unit, FY 2024
Figure 30 : BD: Revenue Shares, by Country/Region, FY 2024
Figure 31 : Integra LifeSciences: Revenue Shares, by Business Segment, FY 2024
Figure 32 : Integra LifeSciences: Revenue Shares, by Country/Region, FY 2024
Figure 33 : Johnson & Johnson Services Inc.: Revenue Shares, by Business Segment, FY 2024
Figure 34 : Johnson & Johnson Services Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 35 : Medtronic: Revenue Shares, by Business Segment, FY 2024
Figure 36 : Medtronic: Revenue Shares, by Country/Region, FY 2024
Figure 37 : MIMEDX Group Inc.: Revenue Shares, by Business Segment, FY 2024
Figure 38 : Organogenesis Inc.: Revenue Shares, by Business Segment, FY 2024
Figure 39 : Smith+Nephew: Revenue Shares, by Business Segment, FY 2024
Figure 40 : Smith+Nephew: Revenue Shares, by Country/Region, FY 2024
Figure 41 : Stryker: Revenue Shares, by Business Segment, FY 2024
Figure 42 : Stryker: Revenue Shares, by Country/Region, FY 2024
Figure 43 : Zimmer Biomet: Revenue Shares, by Business Segment, FY 2024
Figure 44 : Zimmer Biomet: Revenue Shares, by Country/Region, FY 2024